Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02274844 · ClinicalTrials.gov registry record · NA
Improving Medication Adherence in the Alabama Black Belt
A NA study of Diabetes Mellitus and Medication Adherence, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 473
- Enrollment target
- 1
- Study location
NCT02274844: Completed NA study of Diabetes Mellitus and Medication Adherence, sponsored by Weill Medical College of Cornell University.
NCT02274844 is a NA study of Diabetes Mellitus and Medication Adherence that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 473 participants, below the 1,865-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02274844, a NA study of Diabetes Mellitus and Medication Adherence, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 473 participants
- Enrollment target
- 1
- Study location
Study Summary
Medication adherence is especially critical in regions like rural Alabama, where residents have among the worst health outcomes in the US. This project was designed in collaboration with our community member partners and builds on a 5-year partnership of community-engaged research on diabetes peer coaching interventions and our experience with peer storytelling. The investigators will test the hypothesis that an intervention designed within the Corbin and Strauss framework can improve adherence and health outcomes compared to usual care.
Primary Outcome
Patient-reported adherence to medications as a medication adherence score, from 0-3, where a higher score indicates worse adherence.
Conditions Studied
Interventions
- BEHAVIORAL Living Well with Diabetes Program
Study Locations (1)
Alabama
- Univeristy of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 473 participants |
| Start Date | 2016-04 |
| Est. Completion | 2019-01-31 |
| Phase | NA |
What the finished NCT02274844 record still lists
NCT02274844 is an interventional study that assigns participants to a tested intervention. The registered 473 participants enrollment target is mid-sized for trials with a published cap, below the 1,865-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (75% lower).
The record links to 2 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Living Well with Diabetes Program is the first listed.
NCT02274844 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT02274844 about?
NCT02274844 is a clinical study titled "Improving Medication Adherence in the Alabama Black Belt". Medication adherence is especially critical in regions like rural Alabama, where residents have among the worst health outcomes in the US. This project was designed in collaboration with our community member partners and builds on a 5-year partnership of community-engaged research on diabetes peer c...
What is the current status of trial NCT02274844?
This trial is currently completed. It is a NA study. The enrollment target is 473 participants. The study started on 2016-04. Estimated completion is 2019-01-31.
What conditions does trial NCT02274844 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Medication Adherence.
What interventions are being tested in trial NCT02274844?
The interventions under investigation include: Living Well with Diabetes Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02274844?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02274844 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02274844's enrollment target sits among peer trials
473 51st of 208 higher than 158 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05624996 · 474 participants · Phase 3
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- NCT06051695 · 474 participants · Phase 1
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- NCT06632977 · 474 participants · Phase 2
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- NCT06375083 · 472 participants · Phase 2
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia